← Back to headlines
US FDA Proposes Curbs on Mass Compounding of Weight-Loss Drugs
The U.S. FDA has proposed new restrictions on the mass compounding of weight-loss drugs manufactured by Novo Nordisk and Eli Lilly.
30 Apr, 17:56 — 30 Apr, 17:56
Sources
Showing 1 of 1 sources
